Meghani P[au] - Search Results

Year	Number of Results
1992	1
1999	1
2001	1
2002	1
2003	2
2004	1
2008	1
2015	1
2017	1
2022	0

1

Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists.

Austin RP, Bennion C, Bonnert RV, Cheema L, Cook AR, Cox RJ, Ebden MR, Gaw A, Grime K, Meghani P, Nicholls D, Phillips C, Smith N, Steele J, Stonehouse JP. Austin RP, et al. Among authors: meghani p. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1616-20. doi: 10.1016/j.bmcl.2015.01.067. Epub 2015 Feb 3. Bioorg Med Chem Lett. 2015. PMID: 25708618

2

The medicinal chemistry of the P2 receptor family.

Guile SD, Ince F, Ingall AH, Kindon ND, Meghani P, Mortimore MP. Guile SD, et al. Among authors: meghani p. Prog Med Chem. 2001;38:115-87. doi: 10.1016/s0079-6468(08)70093-6. Prog Med Chem. 2001. PMID: 11774794 Review. No abstract available.

3

From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y₂ receptor.

Kindon N, Davis A, Dougall I, Dixon J, Johnson T, Walters I, Thom S, McKechnie K, Meghani P, Stocks MJ. Kindon N, et al. Among authors: meghani p. Bioorg Med Chem Lett. 2017 Nov 1;27(21):4849-4853. doi: 10.1016/j.bmcl.2017.09.043. Epub 2017 Sep 21. Bioorg Med Chem Lett. 2017. PMID: 28958619

4

Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2.

Nicholls DJ, Tomkinson NP, Wiley KE, Brammall A, Bowers L, Grahames C, Gaw A, Meghani P, Shelton P, Wright TJ, Mallinder PR. Nicholls DJ, et al. Among authors: meghani p. Mol Pharmacol. 2008 Nov;74(5):1193-202. doi: 10.1124/mol.107.044610. Epub 2008 Aug 1. Mol Pharmacol. 2008. PMID: 18676678

5

Novel N-aryl and N-heteroaryl sulfamide synthesis via palladium cross coupling.

Alcaraz L, Bennion C, Morris J, Meghani P, Thom SM. Alcaraz L, et al. Among authors: meghani p. Org Lett. 2004 Aug 5;6(16):2705-8. doi: 10.1021/ol049091l. Org Lett. 2004. PMID: 15281749

6

Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists.

Marriott DP, Dougall IG, Meghani P, Liu YJ, Flower DR. Marriott DP, et al. Among authors: meghani p. J Med Chem. 1999 Aug 26;42(17):3210-6. doi: 10.1021/jm980409n. J Med Chem. 1999. PMID: 10464008

7

Chiral 2,2'-bipyridine-type N-monoxides as organocatalysts in the enantioselective allylation of aldehydes with allyltrichlorosilane.

Malkov AV, Orsini M, Pernazza D, Muir KW, Langer V, Meghani P, Kocovský P. Malkov AV, et al. Among authors: meghani p. Org Lett. 2002 Mar 21;4(6):1047-9. doi: 10.1021/ol025654m. Org Lett. 2002. PMID: 11893218

8

Synthesis of new chiral 2,2'-bipyridine ligands and their application in copper-catalyzed asymmetric allylic oxidation and cyclopropanation.

Malkov AV, Pernazza D, Bell M, Bella M, Massa A, Teplý F, Meghani P, Kocovský P. Malkov AV, et al. Among authors: meghani p. J Org Chem. 2003 Jun 13;68(12):4727-42. doi: 10.1021/jo034179i. J Org Chem. 2003. PMID: 12790576

9

New Lewis-basic N-oxides as chiral organocatalysts in asymmetric allylation of aldehydes.

Malkov AV, Bell M, Orsini M, Pernazza D, Massa A, Herrmann P, Meghani P, Kocovský P. Malkov AV, et al. Among authors: meghani p. J Org Chem. 2003 Dec 12;68(25):9659-68. doi: 10.1021/jo035074i. J Org Chem. 2003. PMID: 14656092

10

(R)-2-(3-mercapto-2(S)-methyl-1-oxo-propoxy)-3-(methylthio)propanoic acid, the first ultra-short-acting angiotensin converting enzyme inhibitor.

Baxter AJ, Carr RD, Eyley SC, Fraser-Rae L, Hallam C, Harper ST, Hurved PA, King SJ, Meghani P. Baxter AJ, et al. Among authors: meghani p. J Med Chem. 1992 Oct 2;35(20):3718-20. doi: 10.1021/jm00098a019. J Med Chem. 1992. PMID: 1433185 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results